1. Pourkazemi A, Farashbandi H, Balu H. Epidemiological study of nosocomial infections and antibiotic resistance patterns In Guilan. Yafteh. 2019;21(1).
2. Darvishi M, Forootan M, Nazer MR, Karimi E, Noori M. Nosocomial Infections, Challenges and Threats:A Review Article. Iran J Med Microbiol. 2020;14(2):162-81.
3. Khan HA, Baig FK, Mehboob R. Nosocomial infections: Epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017 May 1;7(5):478-82.
4. Tolera M, Abate D, Dheresa M, Marami D. Bacterial nosocomial infections and antimicrobial susceptibility pattern among patients admitted at hiwot fana specialized university hospital, Eastern Ethiopia. Adv Med. 2018 Dec 4;2018.
5. Despotovic A, Milosevic B, Milosevic I, Mitrovic N, Cirkovic A, Jovanovic S, et al. Hospital-acquired infections in the adult intensive care unit—Epidemiology, antimicrobial resistance patterns, andrisk factors for acquisition and mortality. Am J Infect Control. 2020.
6. Puchter L, Chaberny IF, Schwab F, Vonberg R-P, Bange F-C, Ebadi E. Economic burden of
nosocomial infections caused by vancomycin-resistant enterococci. Antimicrob Resist Infect Control. 2018;7(1):1-7.
7. Metersky ML, Kalil AC. New guidelines for nosocomial pneumonia. Curr Opin Pulmonary Med. 2017 May 1;23(3):211-7.
8. Stiller A, Schröder C, Gropmann A, Schwab F, Behnke M, Geffers C, Sunder W, Holzhausen J, Gastmeier P. ICU ward design and nosocomial infection rates: a cross-sectional study in Germany. J Hosp Infect. 2017 Jan 1;95(1):71-5.
9. Ang H, Sun X. Risk factors for multidrug‐resistant Gram‐negative bacteria infection in intensive care units: A meta‐analysis. Int J Nurs Pract. 2018;24(4):e12644.
10. Chia PY, Sengupta S, Kukreja A, Ponnampalavanar SSL, Ng OT, Marimuthu K. The role of hospital environment in transmissions of multidrug-resistant gram-negative organisms. Antimicrob Resist Infect Control. 2020;9(1):29.
11. Siwakoti S, Subedi A, Sharma A, Baral R, Bhattarai NR, Khanal B. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal-a prospective cohort study. Antimicrob Resist Infect Control. 2018;7(1):114.
12. Zeinali Aghdam S, Minaeian S, Sadeghpour Karimi M, Tabatabaee Bafroee AS. The antibacterial effects of the mixture of silver nanoparticles with the shallot and nettle alcoholic extracts. J Appl Biotechnol Rep. 2019 Dec 5;6(4):158-64.
13. Lepape A, Jean A, De Waele J, Friggeri A, Savey A, Vanhems P, et al. European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria. Antimicrob Resist Infect Control. 2020;9(1):1-11.
14. Khoshfetrat M, Keykha A, Sedaghatkia M, Farahmandrad R. Determination of Antibiotic Resistance Pattern of Organisms Isolated from Endotracheal Tube Cultures of Patients Admitted to Intensive Care Unit. Arch Anesthes Crit Care. 2020 Aug 18.
15. Hemmati A, Nikoonejad AR, Lotfollahi L, Jahed S, Nejad Rahim R, Nabizadeh E. Antibacterial resistance pattern of microorganisms isolated from posetive blood cultures at ICUs of Imam Koeinihospital. J Urmia Univ Med Sci. 2016;27(6):533-40.
16. Khashei R, Navabi Z, Mohebi S, Samadi N. Antibiotic Resistance Among Escherichia coli,Pseudomonas aeruginosa and Acinetobacter baumannii Isolates Obtained From Shiraz Nemazi Hospital ICU Wards. Iran J Med Microbiol. 2018;12(4):294-300.
17. Salehifar E, Abedi S, Mirzaei E, Kalhor S, Eslami G, Ala S, et al. Profile of Microorganisms Involved in Nosocomial Pneumonia and Their Antimicrobial Resistance Pattern in Intensive Care Units of Imam Khomeini Hospital, Sari, 2011-2012. J Mazandaran Univ Med Sci. 2013.
18. Bayani M, Siadati S, Rajabnia R, Taher AA. Drug resistance of Pseudomonas aeruginosa and Enterobacter cloacae isolated from ICU, Babol, Northern Iran. Int J Mol Cell Med. 2013;2(4):204.
19. Molazade A, Gholami MS, Shahi A, Najafipour S, Mobasheri F, Ashraf Mansuri J, Jafari S. Evaluation of Antibiotic Resistance Pattern of Isolated Gram-Negative Bacteria from Urine Culture of Hospitalized patients in Different Wards of Vali-Asr Hospital in Fasa During the Years 2012 and 2013. J Fasa Univ Med Sci. 2014 Sep 1;4(3).
20. Xie J, Roberts JA, Lipman J, Cai Y, Wang H, Zhao N, et al. Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations. Int J Antimicrob Agents.
2020 Jun;55(6):105943.
21. Jeannot K, Bolard A, Plesiat P. Resistance to polymyxins in Gram-negative organisms. Int J Antimicrob Agents. 2017;49(5):526-35.
22. Velkov T, Dai C, Ciccotosto GD, Cappai R, Hoyer D, Li J. Polymyxins for CNS infections: pharmacology and neurotoxicity. Pharmacol Ther. 2018;181:85-90.